← Back to Search

Diagnostic Test

Study Groups for Coronavirus Pandemic

N/A
Waitlist Available
Research Sponsored by 3EO Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-16 weeks
Awards & highlights

Study Summary

This trial is testing a new COVID-19 test to see if it's accurate. Nasal samples will be collected and compared to results from another, already established test.

Eligible Conditions
  • Coronavirus Pandemic

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation of the 3EO Health SARS-CoV-2 standard of care (PCR) Zymo rRT-PCR results of the anterior nare sample.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study GroupsExperimental Treatment1 Intervention
Positives: Symptomatic vs. Asymptomatic Negatives: Symptomatic vs. Asymptomatic Each broken down by age groups: 2-14 years old 15-24 years old 25-64 years old 65+ years old

Find a Location

Who is running the clinical trial?

3EO HealthLead Sponsor
1 Previous Clinical Trials
202 Total Patients Enrolled
Jerika AcostaStudy DirectorMedicept Inc
1 Previous Clinical Trials
202 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~26 spots leftby Apr 2025